ARGX:NASDAQ
argenx SE - ADR
$990.57
arrow_upward
+0.66%(+6.53) 1D
Sep 11, 11:09:54 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$1,001.62
High
$1,002.95
Low
$986.86
Mkt. cap
62.18B
Avg. vol.
281.96K
Volume
42.74K
P/E ratio
37.63
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
Open
$1,001.62
High
$1,002.95
Low
$986.86
Mkt. cap
62.18B
Avg. vol.
281.96K
Volume
42.74K
P/E ratio
37.63
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
ad-hoc-news.de
·
3 hours ago
Argenx stock trades near 12-month high as analysts see further upside
GuruFocus
·
3 days ago
ARGX Reiterates by Wedbush -- Price Target Maintained at $1150
Investing.com
·
3 days ago
argenx at wells fargo healthcare conference: broadening beyond vyvgart
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR